compound 17b [PMID: 35286086]   Click here for help

GtoPdb Ligand ID: 11941

Compound class: Synthetic organic
Comment: This compound is a gefitinib-tamoxifen hybrid molecule, that was developed to combat triple-negative breast cancer [1]. It simultaneously targets both estrogen receptor and epidermal growth factor receptor (EGFR) pathways to block cancer cell growth.
Click here for help
2D Structure
Click here for help
Click here for structure editor
Physico-chemical Properties
Click here for help
Hydrogen bond acceptors 6
Hydrogen bond donors 3
Rotatable bonds 23
Topological polar surface area 118.07
Molecular weight 845.37
XLogP 10.65
No. Lipinski's rules broken 2
SMILES / InChI / InChIKey
Click here for help
Canonical SMILES COc1cc2ncnc(c2cc1OCCCNC(=O)CCCCCN(CCOc1ccc(cc1)/C(=C(\c1ccccc1)/CC)/c1ccc(cc1)O)C)Nc1ccc(c(c1)Cl)F
Isomeric SMILES Clc1cc(Nc2c3c(cc(c(OCCCNC(=O)CCCCCN(C)CCOc4ccc(/C(=C(\c5ccccc5)/CC)/c5ccc(O)cc5)cc4)c3)OC)ncn2)ccc1F
InChI InChI=1S/C49H53ClFN5O5/c1-4-40(34-12-7-5-8-13-34)48(35-15-20-38(57)21-16-35)36-17-22-39(23-18-36)60-29-27-56(2)26-10-6-9-14-47(58)52-25-11-28-61-46-31-41-44(32-45(46)59-3)53-33-54-49(41)55-37-19-24-43(51)42(50)30-37/h5,7-8,12-13,15-24,30-33,57H,4,6,9-11,14,25-29H2,1-3H3,(H,52,58)(H,53,54,55)/b48-40-
InChI Key RMOTTYOBLRRJDT-XXBDBSAUSA-N
Selectivity at nuclear hormone receptors
Key to terms and symbols Click column headers to sort
Target Sp. Type Action Value Parameter Concentration range (M) Reference
Estrogen receptor-α Hs Antagonist Antagonist 8.3 pIC50 - 1
pIC50 8.3 (IC50 4.6x10-9 M) [1]
Selectivity at catalytic receptors
Key to terms and symbols Click column headers to sort
Target Sp. Type Action Value Parameter Concentration range (M) Reference
epidermal growth factor receptor Hs Inhibitor Inhibition 8.6 pIC50 - 1
pIC50 8.6 (IC50 2.5x10-9 M) [1]